MCO
42
5
WY
54
-3
PRGO
40
3
WEC
50
4
NRG
69
14
GILD
62
3
BA
52
2
EL
50
2
PAYX
17
2
CFG
57
2
CTAS
33
-4
CVS
57
-8
COST
56
3
ALLE
66
2
AIV
19
2
CHRW
42
6
V
36
-4
MPC
75
4
MAS
54
-4
ED
65
4
MCO
42
5
WY
54
-3
PRGO
40
3
WEC
50
4
NRG
69
14
GILD
62
3
BA
52
2
EL
50
2
PAYX
17
2
CFG
57
2
CTAS
33
-4
CVS
57
-8
COST
56
3
ALLE
66
2
AIV
19
2
CHRW
42
6
V
36
-4
MPC
75
4
MAS
54
-4
ED
65
4
Financhill
Back

Bristol Myers Squibb Co. 10K Form

Buy
64

BMY
Bristol Myers Squibb Co.

Last Price:
$60.73
Seasonality Move:
2.01%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BMY News And Ratings

See the #1 stock for the next 7 days that we like better than BMY

BMY Financial Statistics

Sales & Book Value

Annual Sales: $48.2B
Cash Flow: $1.6B
Price / Cash Flow: 9.64
Annual Sales: $9.07
Price / Book: 6.7

Profitability

EPS (TTM): 3.45870
Net Income (TTM): $7.1B
Gross Margin: $31.8B
Return on Equity: 39.9%
Return on Assets: 7.56%

Bristol Myers Squibb Co. Earnings Forecast

Key Bristol Myers Squibb Co. Financial Ratios

  • The Gross Profit Margin over the past 46 years for BMY is 65.90%.
  • The Selling, General & Administrative Expenses for BMY have been equal to 15.08% of Gross Profit Margin.
  • The Research & Development expenses have been 19.70% of Revenue.
  • The Interest Expense is 26.80% of Operating Income.
  • The Net Earning history of BMY is 14.64% of Total Revenues.
  • Per Share Earnings over the last 46 years have been positive in 21 years.

Bristol Myers Squibb Co. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: BMY
CUSIP: 110122
Website: bms.com

Debt

Debt-to-Equity Ratio: 2.55
Current Ratio: 1.26
Quick Ratio: 0.88

Price-to-Earnings

Trailing P/E Ratio: 17.56
Forward P/E Ratio: 10.08

BMY Technical Analysis vs Fundamental Analysis

Buy
64
Bristol Myers Squibb Co. (BMY) is a Buy

Is Bristol Myers Squibb Co. a Buy or a Sell?